By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — ...

Liver cirrhosis is a serious condition in which healthy liver tissue is replaced by scar tissue, severely affecting the liver ...

OCALIVA remains available for the treatment of appropriate PBC patients in the U.S. under accelerated approval status.

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

Researchers at the Medical University of South Carolina revealed the need to clarify current treatment guidelines for ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Researchers at the Medical University of South Carolina have revealed the need to clarify current treatment guidelines for ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis ...

Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India, Japan and Chile, and are pending in eight ...